Inventor · disambiguated record
Bernhard Günther
Also filed as: GUENTHER BERNHARD · GUNTHER BERNHARD · GÜNTHER BERNHARD
31 granted patents·17 pending applications·599 citations·filing 2006–2025
98Inventor score
Files withNOVALIQ GMBH32THEISINGER BASTIAN9GUNTHER BERNHARD3DERMALIQ THERAPEUTICS INC2GÜNTHER HOLDING GMBH & CO KG1
Top patents by PatentIndex Score
48 records- 0197US11844836B2Topical pharmaceutical composition based on semifluorinated alkanesDERMALIQ THERAPEUTICS INC·Filed 2020·Granted Dec 19, 2023·6 cites·12 claims
- 0297US11160865B2Liquid pharmaceutical composition for the delivery of active ingredientsTHEISINGER BASTIAN·Filed 2018·Granted Nov 2, 2021·15 cites·22 claims
- 0397US9757459B2Liquid pharmaceutical composition for the delivery of active ingredientsTHEISINGER BASTIAN·Filed 2011·Granted Sep 12, 2017·45 cites·20 claims
- 0496US11583513B2Semifluorinated alkane compositionsNOVALIQ GMBH·Filed 2020·Granted Feb 21, 2023·10 cites·12 claims
- 0596US10813999B2Topical pharmaceutical composition based on semifluorinated alkanesGUNTHER BERNHARD·Filed 2017·Granted Oct 27, 2020·14 cites·23 claims
- 0696US10369117B2Compositions comprising mixtures of semifluorinated alkanesNOVALIQ GMBH·Filed 2017·Granted Aug 6, 2019·18 cites·9 claims
- 0796US10058615B2Semifluorinated alkane compositionsNOVALIQ GMBH·Filed 2017·Granted Aug 28, 2018·26 cites·9 claims
- 0896US10045996B2Pharmaceutical composition for treatment of increased intraocular pressureTHEISINGER BASTIAN·Filed 2011·Granted Aug 14, 2018·36 cites·11 claims
- 0996US9968678B2Liquid pharmaceutical composition for the delivery of active ingredientsTHEISINGER BASTIAN·Filed 2017·Granted May 15, 2018·13 cites·20 claims
- 1096US9770508B2Semifluorinated alkane compositionsNOVALIQ GMBH·Filed 2013·Granted Sep 26, 2017·47 cites·20 claims
- 1196US9308262B2Pharmaceutical composition for administration to nailsGUNTHER BERNHARD·Filed 2012·Granted Apr 12, 2016·55 cites·13 claims
- 1295US12005033B2Compositions comprising mixtures of semifluorinated alkanesNOVALIQ GMBH·Filed 2019·Granted Jun 11, 2024·6 cites·24 claims
- 1395US11987623B2Stabilized antibody compositionsNOVALIQ GMBH·Filed 2021·Granted May 21, 2024·5 cites·20 claims
- 1495US11324757B2Pharmaceutical composition for treatment of increased intraocular pressureNOVALIQ GMBH·Filed 2019·Granted May 10, 2022·7 cites·17 claims
- 1595US10576154B2Semifluorinated alkane compositionsNOVALIQ GMBH·Filed 2018·Granted Mar 3, 2020·17 cites·19 claims
- 1695US10555953B2Pharmaceutical composition for treatment of increased intraocular pressureNOVALIQ GMBH·Filed 2019·Granted Feb 11, 2020·15 cites·17 claims
- 1795US10525062B2Pharmaceutical composition for treatment of increased intraocular pressureTHEISINGER BASTIAN·Filed 2018·Granted Jan 7, 2020·16 cites·10 claims
- 1895US10130707B2Topical pharmaceutical composition based on semifluorinated alkanesGUNTHER BERNHARD·Filed 2012·Granted Nov 20, 2018·31 cites·19 claims
- 1995US9757460B2Stabilised protein compositions based on semifluorinated alkanesNOVALIQ GMBH·Filed 2013·Granted Sep 12, 2017·39 cites·16 claims
- 2095US8614178B2Pharmaceutical composition for treatment of dry eye syndromeTHEISINGER BASTIAN·Filed 2010·Granted Dec 24, 2013·66 cites·13 claims
- 2194US10449164B2Methods of treating ocular disorders using semifluorinated alkanesNOVALIQ GMBH·Filed 2013·Granted Oct 22, 2019·22 cites·11 claims
- 2292US8029977B2Method for preserving organs or limbs using a composition containing a siloxane and a semifluorinated alkane and/or hydrofluoroetherNOVALIQ GMBH·Filed 2006·Granted Oct 4, 2011·47 cites·23 claims
- 2391US11723861B2Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseasesNOVALIQ GMBH·Filed 2018·Granted Aug 15, 2023·7 cites·13 claims
- 2490US11684589B2Pharmaceutical compositions for use in the therapy of blepharitisNOVALIQ GMBH·Filed 2017·Granted Jun 27, 2023·6 cites·12 claims
- 2590US10273298B2Stabilized antibody compositionsNOVALIQ GMBH·Filed 2014·Granted Apr 30, 2019·16 cites·14 claims
- 2687US2025345276A1O/w-emulsions comprising semifluorinated alkanesNOVALIQ GMBH·Filed 2025·Application pending·0 cites
- 2786US11278503B2Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditionsNOVALIQ GMBH·Filed 2018·Granted Mar 22, 2022·7 cites·9 claims
- 2885US11896559B2Opthalmic compositions comprising F6H8NOVALIQ GMBH·Filed 2018·Granted Feb 13, 2024·7 cites·20 claims
- 2984US2024350425A1Compositions comprising mixtures of semifluorinated alkanesNOVALIQ GMBH·Filed 2024·Application pending·0 cites
- 3083US2023139672A1O/w-emulsions comprising semifluorinated alkanesNOVALIQ GMBH·Filed 2022·Application pending·0 cites
- 3181US2023330056A1Semifluorinated alkane compositionsNOVALIQ GMBH·Filed 2023·Application pending·0 cites
- 3275US2022218828A1Topical pharmaceutical composition based on semifluorinated alkanesDERMALIQ THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3373US12496326B2Ophthalmic composition for treatment of dry eye diseaseNOVALIQ GMBH·Filed 2022·Granted Dec 16, 2025·0 cites·16 claims
- 3471US2020360285A1O/w-emulsions comprising semifluorinated alkanesNOVALIQ GMBH·Filed 2020·Application pending·0 cites
- 3570US2023398065A1Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseasesNOVALIQ GMBH·Filed 2023·Application pending·0 cites
- 3666US2019224123A1O/w-emulsions comprising semifluorinated alkanesNOVALIQ GMBH·Filed 2019·Application pending·0 cites
- 3763USRE49758EStabilised protein compositions based on semifluorinated alkanesNOVALIQ GMBH·Filed 2013·Granted Dec 19, 2023·0 cites·35 claims
- 3861US2017216204A1O/w-emulsions comprising semifluorinated alkanesTHEISINGER BASTIAN·Filed 2017·Application pending·0 cites
- 3960US2022079925A1Compositions comprising tacrolimus for the treatment of intraocular inflammatory eye diseasesNOVALIQ GMBH·Filed 2021·Application pending·0 cites
- 4058US2014004197A1O/w-emulsions comprising semifluorinated alkanesTHEISINGER BASTIAN·Filed 2012·Application pending·0 cites
- 4157US2018360908A1Ophthalmic composition for treatment of dry eye diseaseNOVALIQ GMBH·Filed 2018·Application pending·0 cites
- 4256US2019256591A1Stabilized antibody compositionsNOVALIQ GMBH·Filed 2019·Application pending·0 cites
- 4346US2019328717A1Compositions comprising tacrolimus for the treatment of intraocular inflammatory eye diseasesNOVALIQ GMBH·Filed 2017·Application pending·0 cites
- 4445US2013142866A1Compositions and methods for improved organ transplant preservation and acceptanceTHEISINGER BASTIAN·Filed 2011·Application pending·0 cites
- 4542US12310977B2Use of semi-fluorinated alkanes in transdermal therapeutic systemsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Granted May 27, 2025·0 cites·19 claims
- 4642US2014221485A1Lipophilic dopamine derivatives and their useNOVALIQ GMBH·Filed 2012·Application pending·0 cites
- 4739US2019343793A1Compositions comprising a cannabinoid receptor binding ligandNOVALIQ GMBH·Filed 2017·Application pending·0 cites
- 4835US9731326B2Screen device comprising screen rollers for preventing oversize grain from jammingGÜNTHER HOLDING GMBH & CO KG·Filed 2015·Granted Aug 15, 2017·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Bernhard Günther files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →